Regeneron Pharma (REGN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec30

Regeneron Initiates Phase III Clinical Trial for Birch Pollen-Related Eye Allergy Treatment

16:32

Simplify Asset Management Inc. Increased Holdings in Regeneron Pharmaceuticals

13:16

Dec23

Sanofi and Regeneron Obtain Approval for Dupixent for Severe Asthma in Children Aged 6 to 11 from Japan's Ministry of Health

06:00

Dec20

Wall Street Zen downgrades Regeneron Pharmaceuticals' rating from 'buy' to 'hold'

07:24

Dec13

Morgan Stanley Raises Regeneron Pharmaceuticals Target Price

17:21

Dec11

Regeneron Vice President Marion McCourt Sells Shares to Pay Taxes

21:37

Schedules & Filings

Schedules

Filings

Dec5

Distribution Plan(EST)

Cash dividend 0.88 USD

Nov20

Distribution Plan(EST)

Cash dividend 0.88 USD

Distribution Plan(EST)

Cash dividend 0.88 USD

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change